Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.47 |
| ▸ | PPARG | P37231 | 7/20 | 0.47 |
| ▸ | PPARD | Q03181 | 7/20 | 0.47 |
| ▸ | PPARA | Q07869 | 7/20 | 0.47 |
| ▸ | TSHR | P16473 | 6/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | TLR2 | O60603 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | FABP4 | P15090 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.47 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | PDE4A | P27815 | 1/20 | 0.47 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8309477 | 0.84 | TSHR (0.44) | GPR84PPARGPPARDPPARATSHR | |
| SCHEMBL9264898 | 0.76 | GPR84 (0.54) | GPR84PPARGPPARDPPARATSHR | |
| SCHEMBL3799172 | 0.74 | TSHR (0.55) | GPR84PPARGPPARDPPARATSHR | |
| SCHEMBL14505535 | 0.74 | FAAH (0.72) | GPR84PPARGPPARDPPARATSHR | |
| SCHEMBL12982690 | 0.74 | FAAH (0.72) | GPR84PPARGPPARDPPARATSHR | |
| SCHEMBL1647647 | 0.74 | TSHR (0.55) | GPR84PPARGPPARDPPARATSHR | |
| SCHEMBL15135057 | 0.74 | TSHR (0.55) | GPR84PPARGPPARDPPARATSHR | |
| SCHEMBL3905981 | 0.74 | TSHR (0.55) | GPR84PPARGPPARDPPARATSHR | |
| SCHEMBL18573655 | 0.74 | FAAH (0.72) | GPR84PPARGPPARDPPARATSHR | |
| SCHEMBL13113451 | 0.74 | FAAH (0.72) | GPR84PPARGPPARDPPARATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2576502-B1 | NOVEL CHELATOR AND USE THEREOF | CYTIVA BIOPROCESS R & D AB (SE) | 2020-08-05 | — | — | EP | disclosed |
| EP-2576502-B1 | NOVEL CHELATOR AND USE THEREOF | CYTIVA BIOPROCESS R & D AB (SE) | 2020-08-05 | — | — | EP | disclosed |
| US-10662261-B2 | Chelator and use thereof | GE HEALTHCARE BIOPROCESS R&D AB (SE) | 2020-05-26 | — | — | US | disclosed |
| US-10662261-B2 | Chelator and use thereof | GE HEALTHCARE BIOPROCESS R&D AB (SE) | 2020-05-26 | — | — | US | disclosed |
| US-20180223003-A1 | Novel Chelator and Use Thereof | CYTIVA BIOPROCESS R&D AB (SE) | 2018-08-09 | — | — | US | disclosed |
| US-20180223003-A1 | Novel Chelator and Use Thereof | CYTIVA BIOPROCESS R&D AB (SE) | 2018-08-09 | — | — | US | disclosed |
| US-9944722-B2 | Chelator and use thereof | GE HEALTHCARE BIOPROCESS R&D AB (SE) | 2018-04-17 | — | — | US | disclosed |
| US-9944722-B2 | Chelator and use thereof | GE HEALTHCARE BIOPROCESS R&D AB (SE) | 2018-04-17 | — | — | US | disclosed |
| EP-2576502-A1 | NOVEL CHELATOR AND USE THEREOF | GE Healthcare Bio-Sciences AB (SE) | 2013-04-10 | — | — | EP | disclosed |
| US-20130072638-A1 | NOVEL CHELATOR AND USE THEREOF | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2013-03-21 | — | — | US | disclosed |
| US-20130072638-A1 | NOVEL CHELATOR AND USE THEREOF | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2013-03-21 | — | — | US | disclosed |
| WO-2011152782-A1 | NOVEL CHELATOR AND USE THEREOF | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2011-12-08 | — | — | WO | disclosed |
| WO-2011152782-A1 | NOVEL CHELATOR AND USE THEREOF | GE HEALTHCARE BIO-SCIENCES AB (SE) | 2011-12-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180223003-A1 | Novel Chelator and Use Thereof | SPR, ATIC, PHPT1 | GPR84 2749/4885PPARG 4289/4885PPARD 4265/4885 |
| US-10662261-B2 | Chelator and use thereof | ATIC, PHPT1, ADA | GPR84 3026/4885PPARG 4262/4885PPARD 4191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.